Literature DB >> 19191029

The World Health Organization (WHO) histologic classification of thymomas: a reanalysis.

Cesar A Moran1, Saul Suster.   

Abstract

The histologic classification of thymomas has remained for many years an area of conflict. In recent years, the World Health Organization (WHO) presented a proposal for the classification of these tumors, which has been widely adopted in many countries throughout the world. Two successive versions of this classification have been presented in recent years; however, controversy still exists regarding its accuracy and usefulness in clinical practice. We present a review of the current WHO classification of thymomas, with a discussion of some of the inconsistencies and limitations and the possible alternatives to the current approach for the histopathologic classification of these tumors.

Entities:  

Mesh:

Year:  2009        PMID: 19191029     DOI: 10.1007/s11864-009-0084-6

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  27 in total

Review 1.  Thymoma classification: current status and future trends.

Authors:  Saul Suster; Cesar A Moran
Journal:  Am J Clin Pathol       Date:  2006-04       Impact factor: 2.493

2.  Thymoma: a clinicopathologic study.

Authors:  P E BERNATZ; E G HARRISON; O T CLAGETT
Journal:  J Thorac Cardiovasc Surg       Date:  1961-10       Impact factor: 5.209

Review 3.  Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms.

Authors:  S Suster; C A Moran
Journal:  Am J Clin Pathol       Date:  1999-06       Impact factor: 2.493

4.  On the histologic heterogeneity of thymic epithelial neoplasms. Impact of sampling in subtyping and classification of thymomas.

Authors:  C A Moran; S Suster
Journal:  Am J Clin Pathol       Date:  2000-11       Impact factor: 2.493

Review 5.  Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases.

Authors:  S Suster; C A Moran
Journal:  Am J Surg Pathol       Date:  1996-12       Impact factor: 6.394

6.  Thymoma: a clinical and pathological study of 65 cases.

Authors:  W R Salyer; J C Eggleston
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

7.  New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China.

Authors:  Gang Chen; Alexander Marx; Wen-Hu Chen; Jiang Yong; Bernhard Puppe; Philipp Stroebel; Hans Konrad Mueller-Hermelink
Journal:  Cancer       Date:  2002-07-15       Impact factor: 6.860

8.  Reproducibility of a histogenetic classification of thymic epithelial tumours.

Authors:  P M Close; T Kirchner; C J Uys; H K Müller-Hermelink
Journal:  Histopathology       Date:  1995-04       Impact factor: 5.087

9.  Thymoma--a study of 60 cases in Singapore.

Authors:  P H Tan; I T Sng
Journal:  Histopathology       Date:  1995-06       Impact factor: 5.087

10.  Thymoma. A comparative study of clinical stages, histologic features, and survival in 200 cases.

Authors:  J M Verley; K H Hollmann
Journal:  Cancer       Date:  1985-03-01       Impact factor: 6.860

View more
  10 in total

1.  Diminished regulatory T cells in cutaneous lesions of thymoma-associated multi-organ autoimmunity: a newly described paraneoplastic autoimmune disorder with fatal clinical course.

Authors:  T Hanafusa; H Azukizawa; S Kitaba; H Murota; N Umegaki; M Terao; S Sano; T Nakagiri; M Okumura; I Katayama
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

2.  Thymic neoplasm: a rare disease with a complex clinical presentation.

Authors:  Omar M Rashid; Anthony D Cassano; Kazuaki Takabe
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

3.  Thymic epithelial tumor with heart metastasis in a horse.

Authors:  Farshid Shahriar; Janet Moore
Journal:  Vet Med Int       Date:  2010-08-08

4.  99mTc MIBI THYMIC SCINTIGRAPHY IN DIAGNOSIS AND THERAPEUTIC DECISION MAKING: WHAT IS BEHIND THE IMAGE?

Authors:  C Ştefănescu; L Ionescu; R Dănilă; D Butcovan; R Tibu; S Bilha; D Timofte; C Vulpoi
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jul-Sep       Impact factor: 0.877

5.  Metastatic Thymoma-Associated Myasthenia Gravis: Favorable Response to Steroid Pulse Therapy Plus Immunosuppressive Agent.

Authors:  Guoyan Qi; Peng Liu; Huimin Dong; Shanshan Gu; Hongxia Yang; Yinping Xue
Journal:  Med Sci Monit       Date:  2017-03-09

6.  High CTLA-4 expression correlates with poor prognosis in thymoma patients.

Authors:  Giorgio Santoni; Consuelo Amantini; Maria Beatrice Morelli; Daniele Tomassoni; Matteo Santoni; Oliviero Marinelli; Massimo Nabissi; Claudio Cardinali; Vittorio Paolucci; Mariangela Torniai; Silvia Rinaldi; Francesca Morgese; Giovanni Bernardini; Rossana Berardi
Journal:  Oncotarget       Date:  2018-03-30

7.  Correlation of Computed Tomography Parameters with Histology, Stage and Prognosis in Surgically Treated Thymomas.

Authors:  Angelo Carretta; Stefano Viscardi; Piergiorgio Muriana; Paola Ciriaco; Alessandro Bandiera; Roberto Varagona; Michele Colombo; Giampiero Negri
Journal:  Medicina (Kaunas)       Date:  2020-12-24       Impact factor: 2.430

8.  A gene signature to determine metastatic behavior in thymomas.

Authors:  Yesim Gökmen-Polar; Robert W Cook; Chirayu Pankaj Goswami; Jeff Wilkinson; Derek Maetzold; John F Stone; Kristen M Oelschlager; Ioan Tudor Vladislav; Kristen L Shirar; Kenneth A Kesler; Patrick J Loehrer; Sunil Badve
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

9.  A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas.

Authors:  Milan Radovich; Jeffrey P Solzak; Bradley A Hancock; Madison L Conces; Rutuja Atale; Ryan F Porter; Jin Zhu; Jarret Glasscock; Kenneth A Kesler; Sunil S Badve; Bryan P Schneider; Patrick J Loehrer
Journal:  Br J Cancer       Date:  2016-01-14       Impact factor: 7.640

10.  Histotyping of Indian thymomas: A clinicopathologic study from north India.

Authors:  Prerna Guleria; Rajinder Parshad; Prabhat Singh Malik; Ruma Ray; R M Pandey; Deepali Jain
Journal:  Indian J Med Res       Date:  2019-08       Impact factor: 2.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.